Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026
Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address...